From NIH-sponsored research training to senior leadership roles at Johns Hopkins and Yale, Dr. Jeff Geschwind’s career exemplifies excellence in oncology innovation. His contributions to tumor metabolism, image-guided therapy, and cancer drug development continue to transform the future of liver cancer treatment. https://www.bumc.bu.edu/camed/offices-services/alumni/alumni-recognition-resources/alumni-awards-submission/past-recipients-of-the-alumni-awards/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/